CapsoVision (CV) Return on Invested Capital (2025)

CapsoVision's (CV) quarterly Return on Invested Capital came in at 0.01% in Q4 2025, down 477.38% quarter-over-quarter from 0.0% in Q3 2025.

CapsoVision (CV) Return on Invested Capital (2025) Analysis & Trends

CapsoVision has disclosed Return on Invested Capital across 1 years of filings, most recently posting 0.01% for Q4 2025.

Return on Invested Capital for Q4 2025 came in at 0.01%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
Return on Invested Capital came in at 0.01% for Q4 2025 at CapsoVision, down from 0.0% in the prior quarter.
In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q3 2025 to a low of 0.01% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	0.00%
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	0.00%
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	0.00%
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	0.00%
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	0.00%
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	0.00%
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.00%
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	0.00%
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	0.00%
10	CapsoVision	176.55 Mn	166.44 Mn	1.95 Mn	-0.01%

Download Data